KW 2307

Known as: KW-2307 
 

Topic mentions per year

Topic mentions per year

1992-2005
024619922005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A late phase II clinical study (II) of a novel vinca alkaloid derivative KW-2307 (vinorelbine ditartrate) in advanced/recurrent… (More)
Is this relevant?
2002
2002
Vinorelbine (Navelbine, KW-2307), a semisynthetic vinca alkaloid, is a potent inhibitor of mitotic microtubule polymerization… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
Vinorelbine (Navelbine, KW-2307), a semisynthetic vinca alkaloid, is a potent inhibitor of mitotic microtubule polymerization… (More)
Is this relevant?
1995
1995
A multicenter cooperative study was performed to compare KW-2307 (KW), a novel vinca alkaloid (VA) derivative, and vindesine (VDS… (More)
Is this relevant?
1994
1994
A multicenter early Phase II clinical study of KW-2307, a new vinca alkaloid derivative, in patients (pts) with lung cancer was… (More)
Is this relevant?
1994
1994
Phase I study on a new vinca alkaloid derivative, KW-2307(vinorelbine), was conducted by multiple institutions in 40 patients… (More)
Is this relevant?
1994
1994
A phase-I clinical study with coadministration of a new vinca alkaloid derivative KW-2307 with cisplatin (CDDP) at 80 mg/m2 to… (More)
Is this relevant?
1994
1994
A multi-institutional late phase II study of KW-2307 (vinorelbine), a new vinca alkaloid derivative, in advanced or recurrent… (More)
Is this relevant?
1994
1994
A multi-institutional early phase II study of KW-2307 (vinorelbine), a new vinca alkaloid derivative, in advanced or recurrent… (More)
Is this relevant?
1992
1992
The combination effect of navelbine (NVB, KW-2307), a newly synthesized vinca alkaloid, and cisplatin (CDDP) was compared with… (More)
Is this relevant?